FDXR and mitochondrial disease: Furthermore, we will demonstrate that the NRF2/SLC7A11 antioxidant response pathway, which is critical in inhibiting ferroptosis in several biological contexts [40, 69, 70], is downregulated in FDXR-related mitochondrial disease.